Trial Profile
A study investigating clinical efficacy of Certolizumab Pegol in Japanese patients with active rheumatoid arhtritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2017
Price :
$35
*
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism
- 31 Aug 2016 New trial record